The online version of this article (doi:10.1007/s00125-014-3213-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
The NEFA-responsive G-protein coupled receptor 120 (GPR120) has been implicated in the regulation of inflammation, in the control of incretin secretion and as a predisposing factor influencing the development of type 2 diabetes by regulation of islet cell apoptosis. However, there is still considerable controversy about the tissue distribution of GPR120 and, in particular, it remains unclear which islet cell types express this molecule. In the present study, we have addressed this issue by constructing a Gpr120-knockout/β-galactosidase (LacZ) knock-in (KO/KI) mouse to examine the distribution and functional role of GPR120 in the endocrine pancreas.
A KO/KI mouse was generated in which exon 1 of the Gpr120 gene (also known as Ffar4) was replaced in frame by LacZ, thereby allowing for regulated expression of β-galactosidase under the control of the endogenous GPR120 promoter. The distribution of GPR120 was inferred from expression studies detecting β-galactosidase activity and protein production. Islet hormone secretion was measured from isolated mouse islets treated with selective GPR120 agonists.
β-galactosidase activity was detected as a surrogate for GPR120 expression exclusively in a small population of islet endocrine cells located peripherally within the islet mantle. Immunofluorescence analysis revealed co-localisation with somatostatin suggesting that GPR120 is preferentially produced in islet delta cells. In confirmation of this, glucose-induced somatostatin secretion was inhibited by a range of selective GPR120 agonists. This response was lost in GPR120-knockout mice.
The results imply that GPR120 is selectively present within the delta cells of murine islets and that it regulates somatostatin secretion.
ESM Table 1 (PDF 28 kb)125_2014_3213_MOESM1_ESM.pdf
Ichimura A, Hirasawa A, Hara T, Tsujimoto G (2009) Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Lipid Mediat 89:82–88 CrossRef
Miyauchi S, Hirasawa A, Iga T et al (2009) Distribution and regulation of protein expression of the free fatty acid receptor GPR120. Naunyn Schmiedeberg’s Arch Pharmacol 379:427–434 CrossRef
Holliday ND, Watson S-J, Brown AJH (2012) Drug discovery opportunities and challenges at G protein coupled receptors for long chain free fatty acids. Front Endocrinol 2:1–12 CrossRef
Tanaka T, Katsuma S, Adachi T, Koshimizu T, Hirasawa A, Tsujimoto G (2007) Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedeberg’s Arch Pharmacol 377:523–527 CrossRef
Tanaka T, Yano T, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G (2008) Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. Naunyn Schmiedeberg’s Arch Pharmacol 377:515–522 CrossRef
Costanzi S, Neumannm S, Gershengorn MC (2008) Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic and drug discovery aspects. J Biol Chem 238:16269–16273 CrossRef
Hara T, Hirasawa A, Sun Q et al (2009) Novel selective ligands for free fatty acid receptors GPR120 and GPR40. Naunyn Schmiedeberg’s Arch Pharmacol 380:247–255 CrossRef
- GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans
Virginia M. Stone
Katy J. Brocklehurst
Maria Sörhede Winzell
David M. Smith
Noel G. Morgan
- Springer Berlin Heidelberg
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II